AstraZeneca Pharma

6,975.80
+12.65
(0.18%)
Market Cap
17,439.50 Cr
EPS
64.60
PE Ratio
103.55
Dividend Yield
0.35 %
Industry
Healthcare
52 Week High
8,139.00
52 Week low
4,785.00
PB Ratio
25.55
Debt to Equity
0.01
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
29.27 %
Net Income Growth
62.64 %
Cash Flow Change
-52.19 %
ROE
34.50 %
ROCE
36.57 %
EBITDA Margin (Avg.)
-11.30 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
523
571
558
583
745
845
826
820
1,029
1,330
1,652
Expenses
529
547
507
525
657
711
678
719
838
1,111
1,493
EBITDA
-6
23
51
59
88
134
148
101
191
219
159
Operating Profit %
-2 %
3 %
7 %
8 %
10 %
15 %
17 %
11 %
16 %
14 %
8 %
Depreciation
15
17
16
15
15
19
20
17
16
15
26
Interest
0
0
0
0
0
1
1
1
1
1
1
Profit Before Tax
-21
6
36
44
73
114
127
83
134
220
132
Tax
0
1
15
18
18
42
34
21
35
58
53
Net Profit
-21
5
20
26
54
72
93
62
99
162
97
EPS in ₹
-8.34
2.10
8.00
10.40
21.80
28.90
37.30
24.60
39.70
64.60
39.80

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
412
403
416
461
562
706
775
857
985
1,078
Fixed Assets
101
97
87
76
75
72
81
75
69
67
Current Assets
263
267
252
321
405
542
619
706
836
933
Capital Work in Progress
12
6
5
4
7
24
4
2
1
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
298
299
324
382
480
611
690
780
915
1,011
Total Liabilities
412
403
416
461
562
706
775
857
985
1,078
Current Liabilities
260
234
190
207
259
327
304
333
384
357
Non Current Liabilities
1
13
2
7
2
15
15
13
12
9
Total Equity
151
156
223
247
301
364
456
511
589
712
Reserve & Surplus
146
151
218
242
296
359
451
506
584
707
Share Capital
5
5
5
5
5
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-64
53
38
-1
59
-90
269
96
52
5
Investing Activities
-19
-4
0
-9
4
-171
173
5
18
22
Operating Activities
-46
57
38
9
55
87
105
101
58
28
Financing Activities
0
-1
0
0
0
-6
-9
-10
-25
-44

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.69 %
0.00 %
2.74 %
2.79 %
2.90 %
2.93 %
DIIs
0.83 %
0.94 %
0.96 %
1.00 %
1.02 %
1.10 %
1.12 %
1.44 %
1.42 %
1.93 %
2.43 %
2.75 %
3.78 %
5.01 %
5.10 %
5.22 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
19.53 %
19.72 %
19.69 %
19.44 %
19.06 %
18.62 %
18.54 %
18.56 %
18.46 %
18.12 %
17.44 %
17.09 %
16.33 %
15.00 %
14.77 %
14.62 %
Others
4.64 %
4.34 %
4.34 %
4.57 %
4.92 %
5.28 %
5.34 %
5.01 %
5.12 %
4.95 %
2.44 %
5.15 %
2.15 %
2.20 %
2.23 %
2.24 %
No of Share Holders
0
63,753
68,077
66,444
62,183
57,760
53,980
49,085
42,146
38,946
32,380
29,032
29,418
27,169
27,615
27,322

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Technical Indicators

RSI(14)
Neutral
40.67
ATR(14)
Less Volatile
291.89
STOCH(9,6)
Neutral
21.74
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-77.74
ADX(14)
Strong Trend
39.44
UO(9)
Bearish
37.40
ROC(12)
Downtrend And Accelerating
-6.97
WillR(14)
Neutral
-73.58